ElastiMed has developed a wearable medical device, that is designed to improve circulation in the legs, for the treatment of venous and lymphatic diseases.
Based on proprietary technology, that utilizes innovative smart materials, ElastiMed’s sock compresses and massages the legs when stimulated by an electric pulse.
The smart sock is expected to provide patients with a comfortable, easy-to-wear, effective and affordable treatment option to help prevent symptoms such as swelling, blood clots, and leg ulcers.
Based on proprietary technology, that utilizes innovative smart materials, ElastiMed’s sock compresses and massages the legs when stimulated by an electric pulse.
The smart sock is expected to provide patients with a comfortable, easy-to-wear, effective and affordable treatment option to help prevent symptoms such as swelling, blood clots, and leg ulcers.
Location: Israel, North District, Yokneam Ilit
Employees: 11-50
Total raised: $2M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | 4T Venture... | 4t.venture... |
| - | Arc Ventur... | arc-vc.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.09.2017 | - | $1M | - |
| 24.09.2015 | - | $1M | - |
Mentions in press and media 3
| Date | Title | Description |
| 25.09.2017 | ElastiMed Secures US$1M in Funding | ElastiMed Ltd., a Misgav, Israel-based wearable medical device company, raised US$1m in its second round of funding. Backers included The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), Pix Vine Capital and the Israeli Innovation Authority. The... |
| 24.09.2015 | Daily funding roundup - September 24, 2015 | Premise bagged $50M; Replimune closed $30M Series A financing; DriverUp raised $20M Crowdway, a Milan, Italy-based smart platform that generates news and analysis about financial markets, raised €150,000 ($167,400) in seed funding. Backers ... |
| 24.09.2015 | ElastiMed Raises $1M in Venture Capital Funding | ElastiMed, a Tradyon, Israel-based developer of a wearable device using smart materials to treat Chronic Venous Insufficiency (CVI) and to prevent Deep Venous Thrombosis (DVT), raised $1m in funding. Backers included Pix Vine Capital, a Sin... |